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INTRODUCTION
Liver resection (LR) is the most suitable curative treatment for intrahepatic cholangiocarcinoma (ICC). ICC has become a public health issue with an incidence that has increased in all Western countries in the last two decades [1] [2] [3] [4] . Moreover, the prognosis for ICC has not or only slightly improved. Indeed, the median survival ranges between 18 and 39 months 5, 6 . This poor prognosis is first related to the high rate of recurrence, particularly during the first year following liver resection 7 , and to the low rate of resectability. Indeed, in the majority of cases, ICC arises in patients without identifiable underlying liver disease and is thus frequently diagnosed at a late stage with large tumors [8] [9] [10] . In these conditions, the only available curative resection options are extended liver resections (ELR) or orthotopic liver transplantation (OLT). Unfortunately, the first studies that reported on the primary results of OLT in ICC revealed five-year overall survival (OS) rate of only 25% 11 . These poor results are inconceivable in periods of liver graft scarcity. In contrast, with the recent progress in surgical techniques, perioperative management and postoperative care, ELR has become increasingly common, and the risks associated with these major procedures have decreased. For example, portal vein occlusion via ligation or embolization allows for the possibility of increasing the remaining liver and thus reducing the risk of liver failure following ELR.
In recent years, our experiences have revealed an increase in the indications for ELR in ICC from 17% to one-third of cases (Figure 1 .). However, this surgical aggressiveness has not yet been evaluated. Although some reports have analyzed the effects of vascular reconstruction on survival and outcome 12 , none have specifically compared ELR and LR in terms of outcomes and survival.
The aim of the present study was to analyze the outcomes and survival following LR with curative intent for ICC with a special focus on ELR.
METHODS

Patients
The study population included all with curative-intent LRs performed for mass forming type ICCs as defined by the liver Cancer Study Group of Japan at a single tertiary referral center between the 1st of January 1997 and the 1st of September 2013.
Hepatocellular cholangiocarcinoma, gallbladder carcinoma, hilar cholangiocarcinoma and periductal infiltrating types were excluded from the analyses. The clinical data were retrospectively collected from an LR database and analyzed after institutional review board approval was obtained.
Data were collected regarding demographics (i.e., age, sex and body mass index (BMI)), surgical variables, length of hospital stay, morbidity, postoperative chemotherapy and follow-up including disease recurrence and death.
Pathological data, such as the tumor size, satellite nodes, lymph node involvement, UICC 7 th edition TNM staging, perineural invasion and microvascular involvement, were collected.
Surgery
Prior to surgery, each patient was evaluated by thoracoabdominal computed tomography scans with intravenous contrast. Portal vein embolization was indicated when the Liver Resection Volume/total liver volume ratio was < 35%. Extended liver resection (ELR) was defined by the resection of five or more Couinaud liver segments. Right or left hepatectomy extended to segment 1 and right or left trisectionectomy were considered to be ELRs. All LRs were performed with curative intent by senior surgeons. Intraoperative ultrasounds of the liver were performed to ensure the extension and the resectability of the tumor. Vascular or biliary reconstructions (partial or complete) were performed when necessary. Vascular reconstructions were classified into the following three categories: portal vein reconstruction, inferior vena cava reconstruction, and hepatic artery reconstruction. In one case, LR was performed ex situ. The absence of bulky lymph nodes in the celiac or paraaortic area, the absence of tumor residue in the remnant liver and the absence of peritoneal extension defined curative hepatectomies. The resection
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Postoperative morbidity
Postoperative morbidity was defined by any complication that occurred within 90 days after the LR and was categorized according to the Dindo and Clavien classification 13 . Major complications (MC) were categorized as grades III to V in the Dindo and Clavien classification. Postoperative liver failure was defined by the "50-50" criteria on postoperative day 5 as described by Balzan et al. 14 . Postoperative mortality was defined by the occurrence of death within 90 postoperative days.
Survival Analyses
The end of the follow-up was set to be between the 
RESULTS
Demographic and operative data
During the study period, 107 patients underwent LR with curative intent for ICC (82 men and 25 women). ELR was performed in 27 cases (25%). The preoperative data were compared and are shown in the Table 1 . The mean ages were 61.4 ± 10.2 years and 65.6 ± 8.9 years in the ELR and other LR groups, respectively (p=0.07).
The patients' BMIs were greater than 30 in three cases (11.11%) R0 resection rate was similar in both group (74% vs 79% in ELR and other LR group respectively, p=0.81).
The major complication and surgical revision rates were significantly higher in the ELR group than in the other LR group (59.26 vs. 15% (p=0.01) and 29.63 vs. 7.5% (p=0.06), respectively). The liver dysfunction rates were not statistically different (7.41 and 10% in the ELR and other LR group, respectively).
Hospital stay was significantly longer in ELR group than in other LR group ( 13 ± 16.7 days [4-70] and 10 ± 13.3 days , respectively (p=0.02).
The 90-day mortality rate was 9.2% (10 patients) across the entire population, and there was no difference between the two groups (p=1). We have summarized all causes of death in the Supplementary Table 1 . Two patients (7.4%) in the ELR group died; the first death was linked to portal vein and arterial thromboses following an extended right hepatectomy, and the second was linked to major sepsis. were significantly associated with increased risks of major complication. In the multivariate analysis, ELR (OR=6.2, (2.11-19.62), p<0.001) was the only remaining independent risk factor for major complications.
Survival and recurrence analyses
All patients were included in the overall and disease-free survival analyses. The median overall survival of the entire cohort was 32.8 months, and the one-, threeand five-year actuarial survival rates were 79.8, 49.4 and 34.6%, respectively.
Recurrence was observed in 16 ELR patients (59.26%) and 44 other LR patients (55%; p=0.81). Fifty-five percent of the recurrences were at least intrahepatic. The median disease-free survival of the entire cohort was 10.73 months, and the one-, three-and five-year actuarial survival rates were 49.68, 25.7 and 17.4%, respectively.
The overall survival rates and disease-free survival rates were not significantly different between the ELR and the other LR groups, p=0.881 and p=0.228, respectively; Figure 2 .
Univariate and Multivariate Analysis of Variables Affecting Overall Survival
The variables that were thought to have effects on overall survival are reported in p<0.001) were independent risk factors for overall survival (Figure 3 ).
DISCUSSION
Liver resection with curative intent remains the best therapeutic option for ICC The multivariate analysis of the factors associated with major complications revealed that ELR was the only independent risk factor. In this series, the higher rate of MC in the ELR group was probably linked to the complexity of surgeries, which included more vascular or biliary resections and reconstructions. The most frequent complication was biliary leakage, and this finding accords with a finding of our previous report that showed that major LR was an independent risk factor for the occurrence of biliary leakage 16 . These results have recently been confirmed by Zimmity et al. in a large retrospective study of approximately 2628 LRs that showed that increased LR complexity is correlated with the rate of biliary leakage but not with the rates of hemorrhage or perihepatic abscesses 17 . In the present series, the overall 90-day mortality was higher than the recent report of Ali et al.
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. This difference could be partially explained by the lack of selection criterion such as the age or underlying liver disease.
Although portal vein embolization (PVE) was considered preoperatively in all cases, two patients (7.4%) in the ELR group who did not have PVEs developed postoperative liver dysfunction. These results are in line with those of a previously published study 18, 19 . However, these findings might indicate that the operative risk was underestimated in the ICC patients, and therefore inadequate preoperative and operative management was applied. This underestimation is likely based on the false belief that ICCs arise in normal underlying liver parenchyma. Indeed, one might . Several authors have argued that these effects are due to the immunosuppressive effects of blood transfusion and support the role of the immune system in the control of tumor proliferation and progression. Accordingly, it is important to reassert that perioperative allogenic blood transfusion should not be avoided when possible and to emphasize surgical techniques that minimize blood loss. These data further strengthen the need to manage these patients in expert centers to improve the overall prognoses of these tumors.
Obviously, the current study has some limitations. Even if there was no significant difference between the ELR group and the other LR group on confounding variables, there was potentials selection bias. The sample size of the ELR group was quite small even it represented a quarter of our entire population and further studies are needed to confirm the results.
In conclusion, for the first time, this study supports the notion that ELRs for large ICCs do not negatively affect oncological outcomes. These findings argue in favor of aggressive therapeutic strategies for ICC to increase the rate of resectability. In view of ELR results on survival, we can assume that the combination of a neoadjuvant therapy, such as yttrium-90, to decrease the tumor size and increase the remnant liver with ELR is an appealing strategy that should be explored in the near future. Clean version 26/10/14 
